• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of ELISA system for plasma EDL and its clinical application for atherosclerosis

Research Project

Project/Area Number 13557066
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Circulatory organs internal medicine
Research InstitutionKobe University

Principal Investigator

YOKOYAMA Mitsuhiro  Kobe University Graduate School of Medicine, Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Professor, 大学院・医学系研究科, 教授 (40135794)

Co-Investigator(Kenkyū-buntansha) HIRATA Ken-ichi  Kobe University, Kobe University Hospital, Lecturer, 医学部附属病院, 講師 (20283880)
KAWASHIMA Seinosuke  Kobe University Graduate School of Medicine, Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Associate Professor, 大学院・医学系研究科, 助教授 (10177678)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥5,800,000 (Direct Cost: ¥5,800,000)
Fiscal Year 2002: ¥5,800,000 (Direct Cost: ¥5,800,000)
Keywordslipase / lipoprotein / atherosclerosis / endothelial cell / smooth muscle cell / macrophage / coronary arteries / molecular cloning / 高脂血症 / サイトカイン / 炎症 / 高比重リポ蛋白質 / ELISA / HDL
Research Abstract

We and another group have cloned independently a new member of the LPL gene family, endothelial cell-derived lipase (EDL) that is produced by vascular endothelial cells. We have established ELISA system to measure the plasma EDL level in humans and are measuring the plasma EDL levels in normal volunteers and patients with ischemic heart diseases. Conversely, EDL knockout mice showed a marked elevation in HDL cholesterol levels. These data suggest that EDL may play a physiologic role in HDL metabolism. Immunohistochemical analysis revealed that EDL was expressed in endothelial cells and medial smooth muscle cells in non-atherosclerotic coronary arteries. In addition, EDL was detected in infiltrating cells within atheromatous plaques as well as endothelial and smooth muscle cells. To investigate local control of lipase activity and lipid metabolism in the blood vessel wall, we have examined the regulation of EDL expression in HCAECs and HCAECs. EDL mRNA levels were unregulated in both cell types by inflammatory cytokines implicated in vascular disease etiology, including TNF-α and IL-1β. Moreover, both fluid shear stress and cyclic stretch were found to increase the EDL mRNA levels in these cultured cells. To gain better understanding of the function of EDL in vivo, we have generated mice that lack EDL gene. EDL-/- mice are viable and fertile and do not exhibit any overt defects or body weight differences. Fasting plasma HDL cholesterol was increased in heterozygous mutant (EDL+/-) mice, compared with wild type (WT) mice. In contrast, there was no significant difference in triglyceride levels among these genotypes. In conclusion, EDL is an important regulator of HDL metabolism in vivo and likely mediates endothelium-lipoprotein interactions, and EDL in vascular cells may be involved in modulating vessel wall lipid metabolism and may play a role in vascular diseases such as atherosclerosis.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report

Research Products

(38 results)

All Other

All Publications (38 results)

  • [Publications] Rikitake Y: "Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques"Arterioscler Thromb Vasc Biol.. 22. 2049-2053 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ozaki M: "Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle"Am J Pathol.. 160. 1335-1344 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ozaki M: "Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice"J Clin Invest.. 110. 331-340 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Namiki M: "Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion : synergism with hypercholesterolemia"Arterioscler Thromb Vasc Biol.. 22. 108-114 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y: "Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis"Arterioscler Thromb Vasc Biol.. 22. 108-114 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y: "Signaling mechanism underlying cox-2 induction by lysophosphatidylcholin"Biochem Biophys Res Commun.. 281. 1291-1297 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ozaki M: "Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium"Hypertension. 37. 322-327 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kawashima S: "Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling"Arterioscler Thromb Vase Biol.. 21. 201-207 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y: "Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine"Am J Physiol Heart Cire Physiol. 281. H226-H274 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ishida T: "Serotonin-induced hypercontraction through 5-Hydrox-ytryptamine 1B receptors in atherosclerotic rabbit coronary arteries"Circulation. 103. 1289-1295 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hirase T: "Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms"J Biol Chem.. 276. 10423-10431 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y: "Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor contribute to prevention of atherosclerosis in cholesterol-fed rabbits"Atherosclerosis. 154. 87-96 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Okuda M: "Expression of glutaredoxin in human coronary arteries : its potential role in antioxidant protection against atherosclerosis"Arterioscler Thromb Vasc Biol.. 21. 1483-1487 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y, Hirata K, Yamashita T, Iwai K, Kobayashi S, Itoh H, Ozaki M, Ejiri J, Shiomi M, Inoue N, Kawashima S, Yokoyama M: "Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques"Arterioscler Thromb Vasc Biol. 22(12). 2049-2053 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ozaki M, Kawashima S, Yamashita T, Hirase T, Namiki M, Inoue N, Hirata K, Yasui H, Sakurai H, Yoshida Y, Masada M, Yokoyama M: "Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice"J Clin Invest. 110(3). 331-340 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ozaki M, Kawashima S, Hirase T, Yamashita T, Namiki M, Inoue N, Hirata Ki K, Yokoyama M: "Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle"Am J Pathol. 160(4). 1335-1344 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Namiki M, Kawashima S, Yamashita T, Ozaki M, Hirase T, Ishida T, Inoue N, Hirata K, Matsukawa A, Morishita R, Kaneda Y, Yokoyama M: "Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia"Arterioscler Thromb Vasc Biol. 22(1). 115-120 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y, Hirata K, Kawashima S, Ozaki M, Takahashi T, Ogawa W, Inoue N, Yokoyama M: "Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis"Arterioscler Thromb Vasc Biol. 22(1). 108-114 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y, Hirata K, Kawashima S, Takeuchi S, Shimokawa Y, Kojima Y, Inoue N, Yokoyama M: "Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine"Biochem Biophys Res Commun. 281(5). 1291-1297 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ozaki M, Kawashima S, Yamashita T, Ohashi Y, Rikitake Y, Inoue N, Hirata KI, Hayashi Y, Itoh H, Yokoyama M: "Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium"Hypertension. 37(2). 322-327 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kawashima S, Yamashita T, Ozaki M, Ohashi Y, Azumi H, Inoue N, Hirata K, Hayashi Y, Itoh H, Yokoyama M: "Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling"Arterioscler Thromb Vasc Biol. 21(2). 201-207 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y, Kawashima S, Takahashi T, Ueyama T, Ishido S, Inoue N, Hirata K, Yokoyama M: "Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine"Am J Physiol Heart Circ Physiol. 281(1). H266-H274 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ishida T, Kawashima S, Hirata Ki, Sakoda T, Shimokawa Y, Miwa Y, Inoue N, Ueyama T, Shiomi M, Akita H, Yokoyama M: "Serotonin-induced hypercontraction through 5-hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries"Circulation. 103(9). 1289-1295 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hirase T, Kawashima S, Wong EY, Ueyama T, Rikitake Y, Tsukita S, Yokoyama M, Staddon JM: "Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms"J Biol Chem. 276(13). 10423-3 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Rikitake Y, Kawashima S, Takeshita S, Yamashita T, Azumi H, Yasuhara M, Nishi H, Inoue N, Yokoyama M: "Anti-oxidative properties of fluvastatin, and HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits"Atherosclerosis. 154(1). 87-96 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Okuda M, Inoue N, Azumi H, Seno T, Sumi Y, Hirata Ki, Kawashima S, Hayashi Y, Itoh H, Yodoi J, Yokoyama M: "Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis"Arterioscler Thromb Vasc Biol. 21(9). 1483-1487 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Azumi H: "Immunohistochemical localization of endothelial cell-derived lipase in human atherosclerotic coronary arteries"Cardiovasc Res. (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ishida T: "Endothelial lipaseis a major determinant of HDL level"J Clin Invest. 111・3. 347-355 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Rikitake Y: "Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques"Arterioscler Thromb Vasc Biol. 22・12. 2049-2053 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sungshin Y: "Endothelial lipase (EL) : A new lipase on the block"J Lipid Res. 43・11. 1763-1769 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ozaki M: "Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice"J Clin Invest. 110・3. 331-340 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ozaki M: "Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle"Am J Pathol. 160・4. 1335-1344 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Rikitake Y: "Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis"Arterioscler Thromb Vasc Biol.. 22・1. 108-114 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Rikitake Y: "Signaling mechanism underlying cox-2 induction by lysophosphatidylcholine"Biochem Biophys Res Commun.. 281・5. 1291-1297 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ishida T: "Serotonin-induced hypercontraction through 5-Hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries"Circulation. 103・9. 1289-1295 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ozaki M: "Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium"Hypertension. 37・2. 322-327 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kawashima S: "Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling"Arterioscler Thromb Vasc Biol.. 21・2. 201-207 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Rikitake Y: "Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine"Am J Physiol Heart Circ Physiol. 281・1. H226-H274 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2002-03-31   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi